This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (80) Citing Articles via Google Scholar Google Scholar Articles by Huët, C. Articles by Laupacis, A. Search for Related Content PubMed PubMed Citation Articles by Huët, C. Articles by Laupacis, A.

---

CARDIOVASCULAR ANESTHESIA

A Meta-Analysis of the Effectiveness of Cell Salvage to Minimize Perioperative Allogeneic Blood Transfusion in Cardiac and Orthopedic Surgery

Charlotte Huët, MD^*, L. Rachid Salmi, MD, PhD^*, Dean Fergusson, MHA, Ankie W. M. M. Koopman-van Gemert, MD, PhD, Fraser Rubens, MD^§, Andreas Laupacis, MD, and for the International Study of Perioperative Transfusion (ISPOT) Investigators^,1

*INSERM U-330, Université Victor Segalen Bordeaux, Bordeaux, France; Clinical Epidemiology Unit, Loeb Health Research Institute, University of Ottawa, Ottawa, Canada; Hospital Gooi Noord, Blaricum, The Netherlands; and §Ottawa Heart Institute, University of Ottawa, Ottawa, Canada

Address correspondence and reprint requests to Charlotte Huët, INSERM U-330, Université Victor Segalen Bordeaux 2, 146 rue Léo-Saignat, 33076 Bordeaux cedex, France.

Concern about risks of allogeneic transfusion has led to an interest in methods for decreasing perioperative transfusion. To determine whether cell salvage reduces patient exposure to allogeneic blood, we performed meta-analyses of randomized trials, evaluating the effectiveness and safety of cell salvage in cardiac or orthopedic elective surgery. The primary outcome was the proportion of patients who received at least one perioperative allogeneic red cell transfusion. Twenty-seven studies were included in the meta-analyses. Cell salvage devices that do not wash salvaged blood were marginally effective in cardiac surgery patients when used postoperatively (relative risk [RR] = 0.85, 95% confidence interval [CI] = 0.79–0.92). Devices that wash or do not wash salvaged blood considerably decreased the proportion of orthopedic surgery patients who received allogeneic transfusion (RR = 0.39, 95% CI = 0.30–0.51 and RR = 0.35, 95% CI 0.26–0.46, respectively). No studies of cell savers that wash salvaged blood during cardiac surgery were included. Cell salvage did not appear to increase the frequency of adverse events. We conclude that cell salvage in orthopedic surgery decreases the risk of patients’ exposure to allogeneic blood transfusion perioperatively. Postoperative cell salvage in cardiac surgery, with devices that do not wash the salvaged blood, is only marginally effective.

Implications: This meta-analysis of all published randomized trials provides the best current estimate of the effectiveness of cell salvage and is useful in guiding clinical practice. We conclude that cell salvage in orthopedic surgery decreases the proportion of patients requiring allogeneic blood transfusion perioperatively, but postoperative cell salvage is only marginally effective in cardiac surgery.

This article has been cited by other articles:

				G. Wang, D. Bainbridge, J. Martin, and D. Cheng The Efficacy of an Intraoperative Cell Saver During Cardiac Surgery: A Meta-Analysis of Randomized Trials Anesth. Analg., August 1, 2009; 109(2): 320 - 330. [Abstract] [Full Text] [PDF]

				Y. J. Gu, W. J. Vermeijden, A. J. de Vries, J. A. M. Hagenaars, R. Graaff, and W. van Oeveren Influence of Mechanical Cell Salvage on Red Blood Cell Aggregation, Deformability, and 2,3-Diphosphoglycerate in Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass Ann. Thorac. Surg., November 1, 2008; 86(5): 1570 - 1575. [Abstract] [Full Text] [PDF]

				A. T. Tinmouth MD MSc, L. A. McIntyre MD MSc, and R. A. Fowler MDCM MS Blood conservation strategies to reduce the need for red blood cell transfusion in critically ill patients Can. Med. Assoc. J., January 1, 2008; 178(1): 49 - 57. [Abstract] [Full Text] [PDF]

				B. S. Donahue, D. Gailani, M. S. Higgins, D. C. Drinkwater, and A. L. George Jr Factor V Leiden Protects Against Blood Loss and Transfusion After Cardiac Surgery Circulation, February 25, 2003; 107(7): 1003 - 1008. [Abstract] [Full Text] [PDF]

				N. McGill, D. O'Shaughnessy, R. Pickering, M. Herbertson, and R. Gill Mechanical methods of reducing blood transfusion in cardiac surgery: randomised controlled trial BMJ, June 1, 2002; 324(7349): 1299 - 1299. [Abstract] [Full Text] [PDF]

				K. Kottke-Marchant and S. Sapatnekar Hemostatic Abnormalities in Cardiopulmonary Bypass: Pathophysiologic and Transfusion Considerations Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2001; 5(3): 187 - 206. [Abstract] [PDF]

				M H Cross Autotransfusion in cardiac surgery Perfusion, September 1, 2001; 16(5): 391 - 400. [Abstract] [PDF]

				M H Cross Cell salvage and leucodepletion Perfusion, January 1, 2001; 16(1_suppl): 61 - 66. [Abstract] [PDF]